Ovid Therapeutics Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2020 | — | -645.4% | -642.3% |
| FY2021 | — | 59.6% | 58.9% |
| FY2022 | — | -3,696.4% | -3,604.7% |
| FY2023 | — | -15,122.7% | -13,351.8% |
| FY2024 | — | -10,933.7% | -4,670.1% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2020 | — | -645.4% | -642.3% |
| FY2021 | — | 59.6% | 58.9% |
| FY2022 | — | -3,696.4% | -3,604.7% |
| FY2023 | — | -15,122.7% | -13,351.8% |
| FY2024 | — | -10,933.7% | -4,670.1% |